Pavel Rodiukov
Director General at RMI LLC
Graduated from Bauman MSTU with honors (EBM-4 department, 2004)
Professional investor sertificates 1.0 and 5.0 of Central Bank of Russia (2007)
In investment industry since 2000, experience in venture capital since 2004
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.